TGFB1 and cancer: TGF-β is also the main activator of the epithelial–mesenchymal transition (EMT) process during cancer progression, in which epithelial cells break down their junctional structures, begin to express mesenchymal cell proteins, remodel their extracellular matrix, and migrate [44].